Roles > EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor
Page last updated: 2024-08-05 15:34:09

EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor

An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of dihydrolipoyl dehydrogenase (EC 1.8.1.4).

ChEBI ID: 134545

Members (1)

MemberDefinitionClass
5-methoxyindole-2-carboxylic acidAn indolecarboxylic acid that is indole-2-carboxylic acid carrying an additional methoxy substituent at position 5.5-methoxyindole-2-carboxylic acid

Research

Studies (17)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19903 (17.65)18.7374
1990's4 (23.53)18.2507
2000's3 (17.65)29.6817
2010's6 (35.29)24.3611
2020's1 (5.88)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Genome polyprotein Kd4.000011